Alkem Laboratories (India) Financial Diagnostics

ALKEM -- India Stock  

INR 2,067  13.80  0.66%

Alkem Laboratories Limited diagnostics interface makes it easy to digest most current publicly released information about Alkem Laboratories as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Alkem Laboratories price relationship with some important fundamental indicators such as market cap and management efficiency.

Alkem Laboratories Note

The company has Price/Earnings To Growth (PEG) ratio of 2.21. Alkem Laboratories Limited recorded earning per share (EPS) of 52.77. This company last dividend was issued on Augustust 22, 2018. Alkem Laboratories Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India and internationally. Alkem Laboratories Limited was founded in 1973 and is headquartered in Mumbai, India. Alkem Laboratories is traded on Bombay Stock Exchange in India. For more info on N/A please contact the company at 91 22 3982 9999 or go to http://www.alkemlabs.com.

Alkem Laboratories Alerts

On August 22, 2018 Alkem Laboratories paid 7.0 per share dividend to its current shareholders
Latest headline from www.outlookindia.com: Alkem Laboratories Ltd. Stock Share Price Update With Analysis - September 20, 2018

Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 257.83 B.

Profitablity

The company has Profit Margin (PM) of 9.81 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 14.18 % which suggests for every 100 dollars of sales it generated a net operating income of 0.14.

Management Efficiency

Alkem Laboratories Limited has return on total asset (ROA) of 8.01 % which means that it generated profit of $8.01 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.35 % meaning that it generated $13.35 on every $100 dollars invested by stockholders.

Stock Holders for Alkem Laboratories

Information
Ratio
Value
At Risk
TataTata India PharmaHealthcare Dir Gr(0.12) (0.65) 
GrandeurGrandeur Peak Global Opportunities Inv(0.37) (0.76) 
GrandeurGrandeur Peak Global Opportunities Instl(0.37) (0.51) 
SBISBI Magnum MIP Floater Reg Mn Div(1.54) (0.08) 
SBISBI Magnum MIP Floater Reg Gr(1.06) (0.15) 
SBISBI Magnum MIP Floater Reg Ann Div(1.11) (0.11) 
TataTata India PharmaHealthcare Reg Gr 0.00  0.00 
SBISBI Magnum MIP Floater Dir Gr(0.50) (0.07) 
TataTata India PharmaHealthcare Reg Gr 0.00  0.00 
UTIUTI Pharma Healthcare Dir Div(0.18) (2.65) 
SBISBI Magnum MIP Floater Dir Mn Div(0.38) (0.38) 
SBISBI Magnum MIP Floater Reg Ann Div(1.71)  0.00 
SBISBI Magnum MIP Floater Reg Qt Div(1.52)  0.00 
SBISBI Magnum MIP Floater Reg Mn Div(1.85) (0.19) 
UTIUTI Pharma Healthcare Gr 0.00  0.00 
UTIUTI Pharma Healthcare Div 0.00  0.00 

Technical Drivers

Alkem Laboratories Limited shows Downside Deviation of 1.72, Risk Adjusted Performance of 0.0275 and Mean Deviation of 1.36. Alkem Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Alkem Laboratories Limited which can be compared to its rivals. Please confirm Alkem Laboratories Variance as well as the relationship between Maximum Drawdown and Semi Variance to decide if Alkem Laboratories is priced correctly providing market reflects its regular price of 2067.0 per share.

Alkem Laboratories Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Alkem Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Alkem Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Alkem Laboratories Technical and Predictive Indicators

Alkem Laboratories Forecast Models

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Performance Analysis

Also Currentnly Active

Purchased a lot of shares of
3 days ago
Traded for 156.0
Purchased a lot of shares of
3 days ago
Traded for 156.0
Purchased over 300 shares of
3 days ago
Traded for 9.81
Check also Trending Equities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com